World Top 100 HealthCare Products Companies List by Market Cap in January 2024

LHC Group is a Healthcare Services company. It provides high quality care to patients through home health, hospitals, home and community based services and facility based care. The company healthcare services with 32,000 employees operating in 35 states and the district of Columbia reaching 60 percent of the U.S. population aged 65 and older. The headquarters is in USA.

UnitedHealth acquired LHC Group for 5.4 billion USD and closed the deal in Feb-2023.

Bio-pharmaceutical company with headquarters is in Massachusetts, USA.

Hikma Pharmaceuticals is a pharmaceutical company. It develop, manufacture and market nearly 700 quality branded and non branded generic medicines worldwide. The company categories include anti infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory. The headquarters is in UK.

Inspire Medical Systems is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea.

Inspire Medical Systems’ proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

The headquarters is in USA.

Biotechnology company and gene editing company to control couple of human diseases like Cancer and couple of other diseases and it's headquarters is in Switzerland.

With CRISPR/Cas9, they aim to target the source of genetically-defined diseases and engineer the next generation of cellular therapies

Bio-pharmaceutical company with headquarters is in California, USA.

Acadia Pharmaceuticals is a Healthcare and Pharmaceutical company. The company is of food and drug administration for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. Around 8 million people in the United States are living with dementia and studies suggest that approximately 30% of people with dementia, 2.4 million people, experience dementia-related hallucinations and delusion. The headquarters is in USA.